Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",19017,131,1.37 [0.96-1.97],0.0858660904540657
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",19844,152,0.99 [0.63-1.55],0.9583985542282636
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",19639,1149,1.06 [0.91-1.24],0.4216267904692056
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Candidiasis,19856,298,1.10 [0.81-1.47],0.5486755697503397
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,19272,2829,1.03 [0.93-1.13],0.6256395386342306
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),19260,2840,1.18 [1.08-1.29],0.0004171411076085
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,19670,854,1.13 [0.95-1.34],0.1551788934747739
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,19792,65,1.11 [0.59-2.09],0.7365371199243671
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,18029,886,1.17 [0.99-1.38],0.0634246903689847
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,17384,979,1.27 [1.10-1.47],0.001285676875133
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,17205,197,1.14 [0.79-1.63],0.4787874061438553
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,13972,1851,1.13 [1.01-1.26],0.0291934732408796
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,17148,328,1.14 [0.86-1.50],0.3634411320778563
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,19842,1026,1.09 [0.93-1.28],0.2883458480827831
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Mycoses,19925,367,1.03 [0.78-1.36],0.8525139650527045
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,19217,727,1.21 [1.02-1.44],0.03029364187472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,19863,977,1.15 [0.99-1.35],0.0747210943602103
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,18970,154,0.99 [0.63-1.55],0.953573858010018
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,19957,41,1.63 [0.95-2.77],0.074149996008428
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other septicaemia,19738,852,1.16 [0.99-1.37],0.0737090756897417
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,19782,55,0.80 [0.34-1.88],0.6156732292618754
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Other viral diseases,19901,94,1.15 [0.71-1.87],0.5668434614896958
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",19888,81,1.22 [0.74-2.00],0.4353324406694572
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,18883,393,0.86 [0.64-1.17],0.3363339412349434
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,18723,233,0.92 [0.63-1.35],0.6630635744990386
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,18886,70,1.18 [0.67-2.09],0.5573544672607389
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,19939,57,0.92 [0.43-1.97],0.824454838779612
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,19909,125,0.74 [0.42-1.32],0.3081705847611911
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Viral warts,19831,47,0.85 [0.36-2.02],0.7157379804948006
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],19830,46,0.36 [0.11-1.19],0.0936900970094498
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm,19697,293,0.76 [0.53-1.10],0.1502759905333624
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,19897,42,0.42 [0.13-1.42],0.1633014905712791
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,19867,48,0.77 [0.49-1.22],0.2675310824248416
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,19918,108,1.20 [0.78-1.84],0.4142641078706102
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",19644,1388,0.93 [0.80-1.09],0.3756726764287622
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of meninges,19956,25,0.32 [0.06-1.73],0.1835734202672034
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,19905,55,1.56 [0.97-2.50],0.0669970316027162
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,19945,66,1.66 [1.12-2.44],0.0108453419506933
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Ascending colon,19936,386,0.92 [0.69-1.23],0.5748586307512342
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Caecum,19937,291,0.85 [0.59-1.20],0.3515408330546798
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",19847,66,0.95 [0.47-1.89],0.875368814500487
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Descending colon,19933,244,1.12 [0.82-1.54],0.4682475045221309
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Rectum,19897,352,1.04 [0.79-1.37],0.7783613317465863
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,19852,629,0.99 [0.80-1.23],0.9477792429867686
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Benign neoplasm: Transverse colon,19922,462,0.98 [0.76-1.27],0.8942706679759197
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",15528,61,0.79 [0.35-1.77],0.5729375895549993
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",15525,58,0.94 [0.46-1.95],0.875542647000284
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",19929,79,0.87 [0.45-1.68],0.6696469162732972
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Haemangioma, any site",19929,76,0.88 [0.45-1.72],0.7124200998599887
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Lung cancer and mesothelioma,13316,298,1.20 [0.91-1.58],0.1889381044945505
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Lymphoid leukaemia,15522,55,1.09 [0.55-2.14],0.8111006389128611
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",15627,160,1.31 [0.93-1.82],0.1176853689364661
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",15703,236,1.09 [0.78-1.53],0.5944905734137259
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",15546,79,1.07 [0.59-1.96],0.8146617179733348
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",15578,111,0.82 [0.45-1.49],0.5163485149317126
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",15594,127,1.22 [0.81-1.84],0.350465242968743
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",15535,68,0.95 [0.47-1.91],0.8767169148454437
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",16617,1150,1.05 [0.90-1.22],0.5644007715041426
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",15590,123,1.12 [0.72-1.76],0.6085064398173659
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",15563,96,1.55 [1.06-2.25],0.0229204311409892
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,15570,103,1.13 [0.70-1.82],0.6295693741403178
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi,19855,145,0.93 [0.59-1.47],0.7500516209465999
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanocytic naevi of trunk,19931,85,0.94 [0.52-1.70],0.8338934821030487
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Melanoma in situ,15491,59,0.72 [0.31-1.67],0.4406667260984702
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",15550,83,0.96 [0.52-1.76],0.8953048138339523
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",15604,137,1.30 [0.91-1.88],0.150853777004146
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",15660,193,1.27 [0.89-1.80],0.1840417871040473
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",15553,86,1.18 [0.70-1.97],0.5357276370748646
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,Other benign neoplasms of skin,19852,122,0.77 [0.43-1.35],0.3572159905358687
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",16471,1004,1.12 [0.96-1.30],0.1430309795224635
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",16528,1061,1.15 [0.99-1.33],0.0606320367172659
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,19728,247,1.15 [0.85-1.56],0.3599312171583283
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,18548,65,1.18 [0.64-2.17],0.5871841290072739
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,19538,57,1.66 [1.09-2.52],0.0181262440079602
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,19524,2266,1.12 [1.01-1.24],0.0388642881296952
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,18941,51,1.04 [0.50-2.20],0.9080362444440372
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,19600,41,1.02 [0.44-2.34],0.968991852581114
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,19675,1192,1.10 [0.95-1.28],0.1891856129460667
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,19673,1190,1.10 [0.95-1.28],0.187178137269818
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,18560,77,1.07 [0.60-1.91],0.8263875486252256
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,19773,883,1.05 [0.88-1.25],0.6124430809773833
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,19653,94,1.10 [0.66-1.83],0.710981714165948
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,19542,61,1.24 [0.70-2.20],0.459799569027048
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,19535,54,0.96 [0.45-2.04],0.923780533649352
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,19815,256,1.15 [0.85-1.57],0.3672410554328361
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,19880,38,1.06 [0.48-2.35],0.8899624333972139
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",19769,210,1.18 [0.84-1.64],0.3403219848434486
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,18950,60,1.77 [1.19-2.63],0.0050929220124831
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,14799,302,1.28 [0.97-1.68],0.0827202339048373
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,18237,135,0.93 [0.57-1.52],0.7744005679404842
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,18264,162,0.99 [0.64-1.51],0.9457641594795267
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,14545,48,1.33 [0.69-2.59],0.3973018986364893
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,18828,53,1.02 [0.49-2.12],0.9603563742378142
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,18194,182,1.01 [0.68-1.52],0.9527724584049572
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",19571,479,0.98 [0.76-1.26],0.8625814029553689
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,19289,197,1.07 [0.75-1.52],0.7193924486859338
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,19208,116,1.36 [0.94-1.96],0.1025623756426983
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,19713,938,1.17 [1.00-1.37],0.0435940572099078
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,17121,905,1.19 [1.03-1.39],0.0216024556557033
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",14559,62,0.96 [0.46-2.00],0.9177571498323382
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",19251,35,0.31 [0.07-1.32],0.1120913604675278
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,14716,219,1.16 [0.82-1.64],0.4007726497402502
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,14556,59,1.81 [1.22-2.67],0.0030878015609395
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,17696,3199,1.02 [0.92-1.12],0.7212103865377251
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,14650,153,1.16 [0.77-1.77],0.4750773415843899
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,14956,459,1.27 [1.02-1.58],0.0300429884560407
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,19909,229,1.23 [0.91-1.66],0.1763633005367068
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,19752,72,1.51 [0.99-2.33],0.0576610015109615
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,14618,121,1.19 [0.77-1.85],0.4386922882118659
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",14549,52,0.72 [0.28-1.85],0.4972256047333759
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,19805,589,1.24 [1.03-1.49],0.0226481298449673
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,14738,241,1.57 [1.20-2.05],0.0008957154189584
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,14782,285,1.13 [0.83-1.55],0.4342997055502675
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",15103,606,0.83 [0.64-1.07],0.1501183323840483
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,14610,113,1.01 [0.59-1.72],0.977142097774402
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,19746,66,1.61 [1.06-2.44],0.0240644523575032
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,14974,477,1.26 [1.01-1.56],0.0426355346287666
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,14829,332,1.15 [0.86-1.52],0.3415259878461258
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,18060,48,1.26 [0.68-2.34],0.4682756830145517
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,18805,4308,1.08 [1.00-1.17],0.0467274720771396
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,19227,11,0.96 [0.17-5.25],0.9610324668653312
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,19236,20,0.76 [0.18-3.28],0.7111314418472969
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,19818,1471,0.97 [0.84-1.12],0.6859833609563344
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",19816,1468,0.97 [0.84-1.12],0.6886703480250813
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,19229,13,1.70 [0.73-3.92],0.2170189746004255
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,19729,672,1.15 [0.96-1.38],0.1275184847502182
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",15823,1326,1.24 [1.08-1.42],0.0020195308452661
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,19948,196,1.34 [0.97-1.84],0.0733126961453471
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,19176,84,0.86 [0.45-1.66],0.657670122254938
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,19123,66,0.78 [0.36-1.70],0.5373516971041572
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,19130,73,0.81 [0.39-1.67],0.5620625047719905
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",14555,58,1.29 [0.72-2.34],0.3909488841759351
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,17624,140,1.05 [0.67-1.66],0.826156413508979
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2106,103,0.98 [0.58-1.67],0.9407053673676662
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2244,268,0.82 [0.56-1.20],0.3015744871813756
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,17564,80,1.52 [0.96-2.40],0.0751755445292029
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2062,59,1.25 [0.68-2.29],0.4669714741224132
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,19320,1836,1.17 [1.04-1.31],0.006991384054211
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,19361,269,1.15 [0.86-1.54],0.3613591284595696
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,18213,201,1.16 [0.82-1.63],0.4135958607815891
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,15128,631,1.26 [1.03-1.52],0.0211060989330541
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",19850,208,1.05 [0.73-1.50],0.7968871809835242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),18952,233,1.37 [1.04-1.80],0.0259682026316662
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Angina pectoris,17562,1235,1.04 [0.89-1.21],0.6118139717343154
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Aortic aneurysm,19048,329,1.29 [1.02-1.65],0.0367535833746201
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,18785,66,1.30 [0.75-2.28],0.3510934356756614
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",18909,190,1.36 [0.99-1.86],0.0556679266588691
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,11699,1888,1.00 [0.88-1.13],0.9635774244515471
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,AV-block,16113,503,1.01 [0.79-1.29],0.9381228627942768
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",19901,431,1.21 [0.97-1.51],0.0831591593178213
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiac arrest,10020,209,1.44 [1.08-1.92],0.0120443535635866
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cardiomyopathy,15776,166,1.00 [0.65-1.52],0.9820163992915908
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",15696,86,0.67 [0.32-1.41],0.2946060197284444
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,19957,48,1.52 [0.87-2.69],0.1445380492610625
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Conduction disorders,16722,1112,1.16 [1.00-1.35],0.0445214701175137
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,18490,2184,1.04 [0.93-1.17],0.5086273277490967
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,16900,6528,1.01 [0.94-1.07],0.8660355896867384
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,DVT of lower extremities,18941,228,1.05 [0.75-1.48],0.7765852959756325
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Endocarditis,15678,68,1.09 [0.58-2.06],0.7790741960124761
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Heart failure, strict",19695,1092,1.20 [1.03-1.39],0.0169077310188469
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertension,17891,5668,1.01 [0.94-1.08],0.8200706473246522
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, essential",17896,5673,1.01 [0.94-1.08],0.8045253990586874
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, portal",19765,95,1.12 [0.67-1.88],0.6677529380345553
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",12388,165,1.54 [1.16-2.04],0.0026807891374539
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,12324,101,1.85 [1.43-2.40],3.073754892125961e-06
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Hypotension,19840,995,1.19 [1.02-1.38],0.0282066620938695
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,19088,93,1.01 [0.58-1.77],0.96101568315293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",18608,2281,1.00 [0.90-1.13],0.9391863723096696
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",19619,542,1.03 [0.82-1.30],0.7834255951070233
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Left bundle-branch block,15947,337,1.45 [1.16-1.81],0.00097474167613
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,19368,896,1.12 [0.94-1.32],0.1962475490305293
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",17100,773,1.12 [0.94-1.34],0.2219056874119059
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",19821,191,1.30 [0.96-1.78],0.0941038003071042
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",19913,309,0.79 [0.56-1.13],0.2051838988565104
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Oesophageal varices,18767,54,1.18 [0.61-2.28],0.6169640717626343
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other aneurysm,18796,77,0.79 [0.38-1.64],0.5265533842662393
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arrhythmias,16015,405,1.12 [0.87-1.44],0.3964306728378326
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,18829,110,1.48 [1.02-2.16],0.0415647230155296
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,18942,223,1.12 [0.80-1.57],0.5081822372256035
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,15764,154,1.14 [0.76-1.71],0.5422142782152842
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other disorders of veins,18789,76,0.73 [0.34-1.55],0.4072172247529668
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,18754,41,1.49 [0.83-2.66],0.1825374229294886
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,18666,76,0.95 [0.50-1.80],0.8716251638610477
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,18798,85,1.00 [0.55-1.84],0.9920301018272852
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,16634,1024,1.17 [1.00-1.37],0.0437029397136706
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,18897,52,1.52 [0.90-2.58],0.1169862346188086
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,19185,466,1.10 [0.86-1.39],0.4559898347487796
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,19415,308,1.52 [1.23-1.88],8.874598534099962e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",19137,547,1.10 [0.88-1.37],0.3973626564861559
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,10121,310,1.09 [0.81-1.45],0.5818834318381615
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Peripheral artery disease,19100,423,1.14 [0.89-1.47],0.2858457428070695
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),19006,293,1.05 [0.78-1.42],0.7313181681376729
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Pulmonary embolism,19518,411,0.93 [0.71-1.24],0.6375764706310189
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,19905,577,1.09 [0.88-1.35],0.4395265538602657
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Right bundle-branch block,16000,390,1.31 [1.04-1.65],0.0227751629702803
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Secondary right heart disease,19414,307,1.52 [1.23-1.88],0.0001058530909806
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,18770,180,1.23 [0.87-1.74],0.242792390341847
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",19606,611,1.01 [0.81-1.26],0.9120044892994296
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",19596,636,1.02 [0.82-1.26],0.8912416600700384
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,19071,38,0.89 [0.35-2.27],0.8124482658378855
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,18813,95,1.33 [0.87-2.04],0.1854578630998739
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Transient ischemic attack,19269,192,1.11 [0.78-1.58],0.5596848876418548
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,18735,263,1.18 [0.88-1.59],0.2626633780585645
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Varicose veins,19031,318,1.01 [0.75-1.36],0.9491004588533272
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,18735,63,0.75 [0.33-1.70],0.4910726154118618
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter IX Diseases of the circulatory system,Venous thromboembolism,19749,643,0.98 [0.79-1.22],0.8768341106415936
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",19786,414,1.12 [0.88-1.42],0.3718619695261308
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",17199,817,1.15 [0.97-1.36],0.1002651869454419
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Any mental disorder,19382,3000,1.12 [1.02-1.23],0.0153530666258472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",19734,484,1.05 [0.83-1.33],0.6991151399558295
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",17352,970,1.18 [1.02-1.37],0.0302745440104838
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",16445,63,1.01 [0.52-1.98],0.9777124057473856
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Smoking dependency,19407,1293,1.07 [0.92-1.24],0.3668667694060671
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",17944,1562,1.13 [0.99-1.30],0.0713055388055906
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter V Mental and behavioural disorders,Vascular dementia,19573,121,0.91 [0.54-1.55],0.7383616516683422
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Alzheimer disease,19957,248,1.12 [0.82-1.52],0.4792069059429521
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",13371,50,0.90 [0.40-2.04],0.8000773345311648
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Bell's palsy,18821,68,1.43 [0.91-2.25],0.1254894813529817
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,19041,288,1.22 [0.93-1.59],0.149686479317326
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral cysts,19622,190,1.26 [0.92-1.73],0.1573687299941874
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,19884,285,1.09 [0.81-1.47],0.5766048166421494
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,19549,55,1.25 [0.70-2.24],0.4482706230394641
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,19942,66,1.14 [0.63-2.06],0.671545827021826
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",19505,73,1.22 [0.72-2.07],0.4610708219927512
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Epilepsy,18632,232,1.16 [0.85-1.58],0.3504526487808578
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,19519,1119,1.14 [0.99-1.31],0.0779593556191179
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,19924,398,1.07 [0.83-1.38],0.6127140522951922
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Falls/tendency to fall,19498,1780,1.12 [0.99-1.26],0.0608827563537614
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Generalized epilepsy,19638,50,0.74 [0.30-1.81],0.5029436970578782
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hemiplegia,19820,221,1.01 [0.70-1.46],0.9448875500256144
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Hydrocephalus,19480,48,1.31 [0.72-2.40],0.3784678342357443
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,19941,51,0.83 [0.36-1.94],0.6718477334321746
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,18773,20,0.65 [0.14-2.94],0.5741824713300696
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,18832,79,1.56 [1.07-2.26],0.0199764165501675
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Memory loss,19439,105,0.95 [0.55-1.64],0.862993228318062
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Migraine,18559,159,1.31 [0.95-1.80],0.0942967571294621
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",19940,144,1.36 [0.98-1.87],0.0629520737529815
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Motor neuron disease,13470,137,0.94 [0.59-1.50],0.7871915515836002
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,19856,57,0.63 [0.26-1.54],0.313578666615988
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",19567,814,1.16 [0.99-1.37],0.0719946860115792
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Neurological diseases,18858,2943,1.12 [1.02-1.22],0.0150617754952946
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,19678,184,0.87 [0.56-1.35],0.5363394855462733
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",19063,310,0.94 [0.69-1.30],0.7208020877650472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",19878,286,1.16 [0.87-1.54],0.3222507785895011
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,15775,511,1.04 [0.82-1.31],0.7702875195065269
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,19495,63,1.29 [0.76-2.21],0.348736623114783
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other disorders of nervous system,19557,125,0.83 [0.48-1.43],0.49558147262178
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,19635,109,1.18 [0.75-1.86],0.4664379556061946
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other facial nerve disorders,18838,85,1.35 [0.87-2.08],0.1788942427852424
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other headache syndromes,18432,32,0.65 [0.19-2.19],0.4834912451387648
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other neurological diseases,19859,427,1.08 [0.84-1.38],0.5488499977056178
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Other sleep disorders,18982,582,1.12 [0.91-1.37],0.2753350192409095
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Parkinson's disease,19936,269,1.06 [0.78-1.44],0.7238111388164848
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,19453,21,1.68 [0.87-3.22],0.1213386522629055
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Restless leg syndrome,19956,35,0.83 [0.30-2.32],0.7242183332570225
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Sleep apnoea,19712,525,1.15 [0.94-1.42],0.1763509776471727
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Small fibre neuropathy,19639,47,0.82 [0.34-1.97],0.6631187243835339
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,19940,158,0.93 [0.60-1.45],0.748757234287218
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,18781,28,1.01 [0.37-2.76],0.985504056125267
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,19957,250,1.12 [0.82-1.52],0.4750221883586877
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),19546,117,0.91 [0.54-1.56],0.7439532185908887
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,19511,67,0.86 [0.41-1.79],0.6878621109374095
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,19673,246,1.05 [0.75-1.47],0.7687305877335505
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,19804,250,0.96 [0.67-1.39],0.8316510736086196
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,19221,39,0.84 [0.32-2.20],0.7246739113567584
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,19235,53,0.65 [0.25-1.64],0.3566287118948498
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",19882,35,0.98 [0.38-2.54],0.9688447541994046
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,19768,104,0.96 [0.55-1.67],0.8758284598003409
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2062,59,1.23 [0.67-2.27],0.4984251322927323
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2519,108,1.04 [0.62-1.74],0.8791656416208294
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,19526,82,1.03 [0.58-1.83],0.9116127787634108
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,19771,837,0.94 [0.78-1.15],0.5688916178391314
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",19695,513,1.04 [0.82-1.31],0.7576118903436062
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,19298,116,1.15 [0.74-1.79],0.5441408804008597
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",19897,470,1.03 [0.80-1.31],0.8401857002585396
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,19955,55,1.61 [1.03-2.52],0.0354385638211357
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,19846,419,1.01 [0.78-1.31],0.9460554280833464
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",19925,261,0.93 [0.65-1.33],0.6877115969943147
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,19884,122,0.71 [0.39-1.29],0.2593726309818733
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,19246,64,1.06 [0.56-2.02],0.8488572000063404
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,19254,72,1.14 [0.65-2.00],0.6428092283237767
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,19216,34,0.87 [0.32-2.38],0.7893027520650037
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,19879,561,1.06 [0.85-1.31],0.6274016568894043
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,19483,165,0.81 [0.50-1.30],0.3781640527871795
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,19449,22,1.02 [0.33-3.11],0.9756485889790202
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,19744,80,0.80 [0.40-1.62],0.5415288525596559
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,19850,186,0.98 [0.65-1.47],0.9072867474027182
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,19573,146,0.89 [0.56-1.42],0.6301335562794279
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,19827,65,0.77 [0.36-1.67],0.5112785308728848
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,19682,364,1.22 [0.96-1.55],0.1120357694488124
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,19541,97,1.16 [0.71-1.88],0.5606109697485808
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,18831,1478,0.92 [0.79-1.07],0.2809671720479548
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,19825,161,1.03 [0.68-1.57],0.8854114428804234
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,19941,118,1.08 [0.67-1.74],0.7438764657140446
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,19535,353,1.01 [0.76-1.35],0.9237767415291944
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,19721,57,0.77 [0.33-1.80],0.5474243213813563
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,19945,45,1.49 [0.85-2.60],0.1668880330615603
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,19244,62,1.32 [0.79-2.21],0.2902947025440594
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,19305,123,0.99 [0.61-1.61],0.9594856315466204
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,19038,104,1.36 [0.91-2.03],0.1307696861518792
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,19464,37,1.01 [0.42-2.41],0.9793603900514152
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",18988,54,1.12 [0.59-2.13],0.7187767277734843
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,19361,43,0.86 [0.35-2.10],0.7416333280371238
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",19486,168,1.03 [0.69-1.55],0.8793750722751659
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,19276,94,0.95 [0.53-1.70],0.8559349562583036
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,19039,105,0.91 [0.53-1.55],0.7237964121351275
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,19009,75,1.19 [0.70-2.04],0.5218825664529192
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,18548,1195,1.02 [0.87-1.19],0.8457853858506161
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,19229,47,1.11 [0.54-2.28],0.7837809915265193
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,19758,314,1.00 [0.74-1.36],0.9996347571409184
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,19503,59,0.61 [0.24-1.54],0.292964236722376
CEBPA,CCAAT/enhancer-binding protein alpha,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),19566,122,1.01 [0.62-1.64],0.9831985424410236
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,19804,48,1.15 [0.57-2.28],0.6993152583033075
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,19921,106,1.22 [0.79-1.90],0.3671440006341604
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,19843,90,1.25 [0.79-1.99],0.3458726829662963
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,19798,42,0.49 [0.15-1.55],0.2233152443816419
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,19801,45,0.84 [0.34-2.07],0.7101670924498242
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,19871,779,1.23 [1.05-1.45],0.0106415063692149
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,19671,579,1.32 [1.10-1.57],0.0022168184226489
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,19201,109,0.82 [0.45-1.48],0.5051121606284821
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,19159,67,0.79 [0.36-1.70],0.5437857220468352
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute pharyngitis,19778,47,1.39 [0.78-2.45],0.2611083106917161
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,19886,155,1.04 [0.68-1.58],0.8569314219123754
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,19781,50,0.97 [0.44-2.14],0.9306916569125632
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,All influenza,18098,82,1.13 [0.66-1.94],0.6481972527975297
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),18095,79,1.18 [0.70-2.00],0.533179656850951
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Allergic asthma (mode),13104,86,1.00 [0.58-1.74],0.9996442006349554
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Allergic rhinitis,19872,230,0.90 [0.62-1.31],0.5863393594336304
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",13922,1193,1.07 [0.93-1.23],0.341328082813732
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",14188,1170,1.07 [0.93-1.24],0.3510460154485418
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),19630,120,1.21 [0.78-1.86],0.3958548027652651
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",18090,74,1.00 [0.53-1.90],0.9940270109979544
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Bronchiectasis,17337,243,1.11 [0.80-1.53],0.5366019672182061
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",17130,36,0.97 [0.37-2.51],0.9484668958840934
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,19231,2137,1.12 [1.00-1.24],0.0463431822679761
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",18720,66,1.44 [0.90-2.30],0.124223878303896
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Chronic sinusitis,18787,133,0.99 [0.62-1.57],0.9574926608205298
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",19771,1093,1.18 [1.01-1.37],0.0329216247493768
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Deviated nasal septum,18781,127,1.01 [0.64-1.58],0.9802906833549788
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,18254,4368,1.07 [0.99-1.15],0.1094042207058472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",19001,347,0.99 [0.74-1.32],0.9363575063045808
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Early onset COPD,18946,268,1.26 [0.96-1.66],0.0972322346182428
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Emphysema,17398,304,1.17 [0.87-1.56],0.2946867260404157
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,19164,298,1.30 [1.01-1.66],0.0404039015805903
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Influenza and pneumonia,19748,1732,1.17 [1.04-1.31],0.0083374062280953
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Interstitial lung disease,19185,319,1.30 [1.02-1.65],0.0318863991833912
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Later onset COPD,19026,825,1.12 [0.94-1.34],0.2025235155485252
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,19940,331,0.89 [0.65-1.23],0.4972085660053729
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Nasal polyp,18784,130,0.70 [0.39-1.24],0.2218086532091132
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,19724,803,1.03 [0.85-1.24],0.7654540898124969
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of pleura,19720,1830,1.20 [1.08-1.34],0.0012148210678748
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,19408,754,0.95 [0.77-1.15],0.582145379677109
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other pleural conditions,17940,50,1.08 [0.53-2.22],0.8291597483989229
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,19863,388,1.27 [1.02-1.60],0.0339076775565761
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,19850,1167,1.15 [1.00-1.33],0.0536386544940445
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural effusion,18812,922,1.26 [1.09-1.47],0.0021019618875944
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pleural plaque,18117,227,1.33 [1.00-1.78],0.0514805434391197
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",19541,1525,1.20 [1.06-1.35],0.0031323911352311
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,19851,242,0.88 [0.60-1.29],0.5130861119967749
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pneumothorax,18008,118,0.95 [0.57-1.58],0.8373087978370009
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pollen allergy,19944,199,0.96 [0.65-1.40],0.8159619702290068
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Pulmonary oedema,19531,56,1.02 [0.49-2.13],0.9596209096179906
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Respiratory insufficiency,13066,48,1.03 [0.48-2.18],0.9399569729355136
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,19710,789,1.04 [0.86-1.25],0.6973250237209752
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,18885,231,0.90 [0.62-1.31],0.597004485092175
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Viral pneumonia,18241,225,0.85 [0.56-1.28],0.4422338661059282
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",19646,190,0.70 [0.42-1.15],0.1546074409792578
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,8750,100,1.38 [0.91-2.08],0.1292948799175434
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,13974,74,1.85 [1.38-2.50],4.943576175876581e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute appendicitis,19847,119,1.07 [0.68-1.68],0.7726327943366762
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute gastritis,15119,74,1.17 [0.66-2.06],0.5943615091677938
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute pancreatitis,18837,173,1.15 [0.79-1.65],0.4706166718132279
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Acute peritonitis,19657,77,1.23 [0.73-2.08],0.4444471092419727
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Alcoholic liver disease,19200,92,1.36 [0.88-2.09],0.1695571567953813
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Barrett oesophagus,15473,428,1.12 [0.88-1.41],0.3577330861507861
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",18768,104,1.05 [0.62-1.77],0.8519600363812674
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",19622,104,1.05 [0.62-1.76],0.8657946822178348
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholecystitis,18841,177,0.91 [0.59-1.40],0.6598796579278073
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Cholelithiasis,19321,657,1.14 [0.94-1.37],0.1933403649341139
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic gastritis,15261,216,0.93 [0.63-1.37],0.7066211497872519
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Chronic pancreatitis,18711,47,1.49 [0.86-2.59],0.157094997619983
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",19784,114,1.06 [0.64-1.75],0.8194867717118302
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Coeliac disease,18579,77,1.79 [1.32-2.42],0.0001687342623778
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Collagenous colitis,18752,42,1.03 [0.45-2.33],0.9494960331037584
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,19811,184,1.14 [0.80-1.63],0.4748637627649199
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Constipation,19822,1285,1.09 [0.95-1.26],0.2327829881560326
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn disease,18787,77,1.03 [0.57-1.85],0.9297794302339168
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",19672,56,1.07 [0.54-2.10],0.8472795936958547
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Crohn's disease NAS,18774,64,0.87 [0.42-1.81],0.7169475005825059
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Dental caries,19426,188,0.86 [0.56-1.34],0.5079526716219265
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,16927,1615,1.06 [0.94-1.21],0.3421693806750628
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of appendix,19873,145,1.07 [0.71-1.61],0.7459459350216897
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of liver,19838,730,1.07 [0.89-1.30],0.4681725620333938
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",18276,3231,1.02 [0.93-1.12],0.6439829387746192
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",19649,411,0.95 [0.72-1.25],0.7120173624613457
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of peritoneum,19915,335,1.30 [1.03-1.64],0.028639150498081
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,19323,85,0.90 [0.48-1.68],0.729842946016241
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of salivary glands,19215,52,1.63 [1.08-2.46],0.0196719580514722
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of the digestive system,19690,1188,1.02 [0.87-1.19],0.8269357264929054
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diseases of tongue,19228,93,1.03 [0.60-1.76],0.9233679090674212
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",19663,999,1.12 [0.96-1.31],0.1614411290209967
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,16460,2560,0.98 [0.88-1.09],0.7506854249792554
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Duodenal ulcer,15255,210,1.07 [0.75-1.54],0.7025676448070197
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",19854,158,1.14 [0.77-1.68],0.5096186120465748
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,19896,36,1.31 [0.72-2.37],0.3814231335554066
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,19241,133,1.01 [0.63-1.61],0.9831025886948168
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,14049,149,1.16 [0.79-1.70],0.4470268996142761
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Functional dyspepsia,15390,345,1.07 [0.81-1.40],0.6449259139136946
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastric ulcer,15350,305,1.03 [0.75-1.41],0.8588081157191753
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,16837,1792,1.07 [0.95-1.21],0.2403198742402091
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,15530,485,0.97 [0.75-1.25],0.8095947122160881
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,15270,6674,1.05 [0.99-1.12],0.1128903491860573
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,GI-bleeding,19485,983,0.93 [0.78-1.12],0.4431326863424917
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,19280,42,0.74 [0.27-1.99],0.5517451056066932
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,14680,1011,0.96 [0.81-1.13],0.6166407482213555
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",19180,72,1.25 [0.73-2.12],0.415746274476742
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Hernia,18241,2929,1.08 [0.99-1.19],0.0868549967447111
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impacted teeth,19899,35,1.31 [0.72-2.38],0.3715245743573483
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Impaction of intestines,13937,37,0.79 [0.29-2.18],0.6516274881817412
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Inguinal hernia,16687,1375,1.10 [0.96-1.26],0.1611056275578937
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",15473,161,1.04 [0.70-1.55],0.8468578186362271
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,13974,74,0.90 [0.46-1.73],0.7416915617639912
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Intestinal malabsorption,18592,90,1.72 [1.28-2.30],0.000296837097914
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,14139,239,1.02 [0.73-1.42],0.9143234618202504
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,19921,309,1.05 [0.78-1.41],0.7616613621571658
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,19273,563,1.17 [0.96-1.42],0.1277663470269121
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,19448,738,1.14 [0.96-1.36],0.145232070863751
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophageal obstruction,15223,178,1.32 [0.96-1.82],0.0906077640835895
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oesophagitis,15562,517,1.25 [1.02-1.52],0.0273916838023334
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,19908,86,1.32 [0.85-2.04],0.2127295422312555
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,15373,61,0.92 [0.44-1.93],0.8177270387861251
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,15109,1209,0.90 [0.76-1.06],0.1929400047386508
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,18882,218,0.94 [0.64-1.38],0.7696849616101231
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,18764,100,1.24 [0.79-1.93],0.3483184279239008
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestine,15479,1579,0.92 [0.80-1.06],0.2465915945760903
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of intestines,18441,4541,0.98 [0.90-1.06],0.5971201843360373
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,19194,143,1.44 [1.06-1.96],0.0194637470517253
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of liver,19690,582,1.10 [0.89-1.36],0.3597375399315963
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,15643,598,1.13 [0.92-1.37],0.2399188570170226
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of pancreas,18780,116,1.34 [0.90-2.00],0.1482746145630374
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,19861,281,1.34 [1.05-1.71],0.018463291805873
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,15701,656,1.13 [0.93-1.37],0.2058230595105474
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,19494,992,0.92 [0.76-1.10],0.3467705619735411
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,19377,139,0.86 [0.51-1.43],0.5564737594497158
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,15215,1315,1.06 [0.93-1.22],0.38492373805508
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),16591,1546,1.10 [0.97-1.25],0.1465731596895939
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,19184,76,1.09 [0.61-1.94],0.773840747954104
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,19356,646,1.17 [0.98-1.41],0.086757766248968
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",14188,288,1.02 [0.75-1.38],0.9009898947887542
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,19887,44,1.43 [0.90-2.28],0.1339334428486019
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,14290,390,1.00 [0.77-1.31],0.974518927651452
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",18641,139,1.15 [0.76-1.72],0.50957008552479
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Recurring oral aphthae,19943,32,0.74 [0.24-2.30],0.601674074196857
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,19245,81,0.94 [0.52-1.71],0.8415488926747086
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Toxic colitis,18748,38,1.80 [1.11-2.92],0.0164842809900222
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,15293,248,1.32 [1.01-1.73],0.0398281537114616
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ulcerative colitis,18832,122,1.22 [0.82-1.82],0.3285330063495483
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",18811,101,0.95 [0.55-1.63],0.8450108878850638
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Umbilical hernia,15603,291,0.78 [0.54-1.13],0.1882718518491475
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,14037,137,0.63 [0.35-1.13],0.1236183728801469
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Ventral hernia,15525,213,0.98 [0.67-1.44],0.9362752604137912
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XI Diseases of the digestive system,Volvulus,13956,56,1.13 [0.61-2.11],0.6931065211019032
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,19902,261,0.93 [0.66-1.31],0.689651424937908
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,19698,60,1.21 [0.68-2.18],0.5192384097144617
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,18314,78,1.06 [0.60-1.86],0.8419781030854212
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,19334,627,1.00 [0.80-1.24],0.9864480891041134
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",18878,171,0.86 [0.55-1.35],0.5084125795353832
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,18604,368,0.99 [0.74-1.33],0.9637916816869658
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,19708,224,1.06 [0.75-1.49],0.7562341634776274
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,19874,390,1.01 [0.77-1.32],0.9578719540572296
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,19522,38,1.19 [0.57-2.50],0.6410711824207742
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,18696,2614,1.00 [0.90-1.11],0.9963760267867416
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,19577,327,1.01 [0.75-1.35],0.9618859568973412
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,19482,232,1.06 [0.76-1.48],0.7239925871075312
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,19562,855,1.03 [0.86-1.23],0.7482157168359893
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",19947,25,0.93 [0.31-2.86],0.904864521748852
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,18258,22,1.35 [0.58-3.16],0.4844766593288658
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,19298,48,0.72 [0.28-1.86],0.4983631853860611
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,19704,220,1.06 [0.75-1.51],0.7225014479724203
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,18633,397,0.98 [0.75-1.28],0.8858834614427018
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,18301,65,0.93 [0.46-1.88],0.844461225432207
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,19900,68,0.95 [0.48-1.89],0.8926522779079179
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,18871,164,1.21 [0.84-1.73],0.3051055510238248
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,19811,173,1.02 [0.68-1.53],0.9086100559685776
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,19542,58,0.73 [0.31-1.75],0.4836516947476389
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,18288,52,1.08 [0.54-2.15],0.8309325855228469
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,19568,1332,1.04 [0.90-1.20],0.5611105900242915
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",18667,431,0.96 [0.74-1.25],0.7775018366620595
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,18304,68,0.92 [0.46-1.84],0.8179616896264372
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,19880,242,0.96 [0.67-1.37],0.8126128072565659
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,19528,44,0.57 [0.19-1.72],0.3139787003924519
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,19849,211,1.00 [0.69-1.45],0.994883708551189
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,19918,277,0.90 [0.64-1.27],0.5520019443793495
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,18310,74,1.10 [0.63-1.93],0.7452264874230728
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,18459,223,1.03 [0.73-1.45],0.8545308566531806
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,19912,271,0.90 [0.64-1.27],0.5544147898149554
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",18445,209,1.27 [0.92-1.75],0.1491440607119562
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,19934,102,0.90 [0.50-1.60],0.7147109649680895
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,17212,70,1.16 [0.66-2.04],0.6027568676721223
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,18208,3986,1.04 [0.96-1.13],0.3137860056555169
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,17029,2807,0.99 [0.90-1.10],0.8794409142047176
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,17206,64,0.74 [0.33-1.63],0.4527173264835167
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,17546,121,0.68 [0.37-1.25],0.2145490763141778
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,17541,116,1.38 [0.96-1.99],0.0809150286919803
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,19786,55,1.40 [0.87-2.27],0.1649146811250054
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",17489,64,0.70 [0.30-1.63],0.4124452692596915
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,14953,731,0.99 [0.81-1.21],0.9415364944433824
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",19852,126,1.04 [0.65-1.65],0.8836275450637152
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,17646,221,1.26 [0.94-1.69],0.1290584323062944
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,16994,5210,1.04 [0.97-1.12],0.2450131076354115
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,19100,84,0.97 [0.53-1.75],0.9085492127556688
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,17277,135,0.96 [0.59-1.55],0.868693481251058
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,17515,373,0.80 [0.58-1.09],0.160724961669255
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,19258,1833,1.12 [1.00-1.26],0.0524733114781954
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,17456,314,0.75 [0.53-1.07],0.1112341019947107
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,17188,46,1.05 [0.50-2.19],0.9058884860696688
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,17227,85,0.70 [0.34-1.41],0.3164422598283775
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,19688,27,0.81 [0.24-2.74],0.7388975316671944
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,15422,1200,0.92 [0.78-1.08],0.309546342366193
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,15018,796,1.11 [0.93-1.33],0.2421223982068012
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",19837,783,1.10 [0.92-1.32],0.3013115341619722
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,14259,37,1.10 [0.49-2.45],0.8219707982769132
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),14291,69,0.96 [0.50-1.83],0.88965180901481
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,17365,223,1.04 [0.74-1.46],0.8141711857492046
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,14745,523,0.82 [0.63-1.06],0.1216619104040157
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,17460,35,1.57 [0.90-2.75],0.1133224122898914
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,17858,433,1.13 [0.89-1.43],0.3068116989449502
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,17641,216,0.98 [0.68-1.42],0.9079774109604916
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,14709,487,0.81 [0.62-1.06],0.1291775717820422
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,17197,55,0.80 [0.35-1.85],0.6049483109374708
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",17183,41,1.43 [0.80-2.56],0.2228691057978502
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,19092,76,1.53 [1.00-2.34],0.0482344364848054
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,19722,706,1.11 [0.92-1.34],0.2838136823912119
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,19343,327,1.23 [0.96-1.58],0.1023615779918804
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",19892,249,1.22 [0.91-1.64],0.1930292787683406
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,15787,1565,1.01 [0.88-1.15],0.8974690206908117
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,14266,44,0.77 [0.31-1.92],0.5710876316789192
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,17206,64,1.16 [0.65-2.06],0.6230887328250643
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,14271,49,1.47 [0.84-2.59],0.1814457322609701
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),14257,35,1.11 [0.50-2.46],0.7897030332108094
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,19168,152,0.98 [0.64-1.53],0.9436101567849202
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,19147,131,1.10 [0.71-1.69],0.6741451345768683
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,19928,71,1.30 [0.78-2.16],0.3150028168682317
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",18676,1251,1.17 [1.02-1.34],0.020297841779875
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,17195,53,1.03 [0.51-2.06],0.9356761209706168
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),14257,35,0.60 [0.19-1.92],0.3886908136140498
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,17938,513,1.07 [0.85-1.34],0.5681547526517494
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,15657,1435,1.00 [0.87-1.15],0.9982279026250226
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,19704,43,0.72 [0.26-2.00],0.5321442260136533
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,19943,56,1.30 [0.74-2.29],0.3639594759711134
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,17214,72,0.87 [0.44-1.74],0.6936290332552137
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",17949,807,1.13 [0.95-1.34],0.1582465225030243
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,17217,75,0.88 [0.45-1.74],0.7222352140203399
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,15242,1020,1.16 [1.00-1.35],0.0554871652118611
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,19085,69,0.51 [0.21-1.25],0.1408008981432974
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,17180,38,1.02 [0.46-2.26],0.9612599934694738
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,17521,96,0.60 [0.29-1.25],0.1696820451856643
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,17553,411,1.10 [0.86-1.41],0.4447730466262202
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,19822,161,0.79 [0.48-1.28],0.3363390821930445
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,17825,400,1.07 [0.83-1.39],0.5832472238706631
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,19900,245,1.04 [0.74-1.46],0.8216182276975904
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,19944,32,1.47 [0.75-2.88],0.2593334889329279
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,17267,125,1.00 [0.62-1.60],0.9945399590661472
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,16396,484,1.04 [0.82-1.32],0.7442185187925039
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,17536,394,1.16 [0.91-1.47],0.2216210244813547
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],17427,285,0.78 [0.54-1.12],0.1763886695090651
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",14246,24,0.57 [0.13-2.45],0.4464806276451525
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,16118,1896,1.14 [1.02-1.28],0.0177824764558368
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,14579,357,1.06 [0.81-1.40],0.6716017659597864
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,19794,133,0.78 [0.45-1.34],0.3679326565522753
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",19893,36,1.30 [0.64-2.63],0.468894799549443
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",18314,36,0.42 [0.11-1.56],0.1970510372132023
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,14280,58,1.27 [0.73-2.22],0.3996156656559718
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,17500,75,1.16 [0.67-2.01],0.5979162504831227
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,14478,256,1.29 [0.98-1.70],0.0648901434388265
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,17382,240,0.97 [0.68-1.38],0.8641081646873268
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,17609,184,1.38 [1.03-1.85],0.0330943660559258
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,17497,72,1.21 [0.71-2.06],0.4861824111851405
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,15859,27,2.04 [1.23-3.41],0.0060298089121836
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",19945,33,1.60 [0.88-2.91],0.1202305967010016
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,17587,445,1.02 [0.80-1.30],0.8865457534694805
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],19677,16,1.68 [0.78-3.60],0.1842323859911432
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,19050,1908,1.01 [0.90-1.14],0.8498753338252268
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",17233,91,0.90 [0.49-1.63],0.7165355908733193
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,17839,414,0.80 [0.59-1.09],0.1623722468200713
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,19065,166,0.80 [0.49-1.30],0.3651242578619013
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,17540,115,1.04 [0.64-1.71],0.8671714698953215
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,18509,1084,1.00 [0.84-1.18],0.9798077758793804
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,18099,674,1.16 [0.96-1.40],0.1238040761982889
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],17174,32,1.23 [0.58-2.64],0.5901573121948527
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,19697,36,1.34 [0.69-2.62],0.3895308912834379
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,17248,106,0.46 [0.22-0.98],0.0446731003826365
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,17161,19,1.28 [0.45-3.60],0.6445573789753702
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),14273,51,0.94 [0.44-2.04],0.8847793339420671
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Acute renal failure,19218,1490,1.30 [1.15-1.46],1.5463395391841942e-05
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,19561,328,0.84 [0.60-1.17],0.3042954720888688
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,19356,123,1.48 [1.06-2.07],0.0220590511454359
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,18846,1118,1.30 [1.13-1.49],0.0002072055163366
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,19756,49,1.41 [0.81-2.47],0.2266188802886883
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,19755,295,1.26 [0.96-1.65],0.0941697315568153
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Cystitis,17611,167,1.12 [0.77-1.63],0.54908342500982
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Dialysis,17795,67,1.84 [1.28-2.62],0.0008631394432573
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,18908,2766,0.99 [0.90-1.10],0.8924175589397637
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18044,4625,1.07 [0.99-1.16],0.0688747710656541
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,19780,73,1.31 [0.77-2.21],0.31877742502709
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydrocele,16314,172,0.94 [0.61-1.44],0.7694946326460741
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,17796,291,1.23 [0.94-1.61],0.1365909581904191
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,18319,2177,1.03 [0.92-1.16],0.5629450214569106
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),16337,195,0.96 [0.64-1.42],0.8224327690202212
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,17503,59,0.88 [0.42-1.87],0.7424444433177759
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,16241,99,1.17 [0.73-1.88],0.5106116157158491
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",19950,51,1.22 [0.65-2.30],0.5319234016551777
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",19948,42,1.36 [0.73-2.54],0.3342979089613328
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,19276,1832,1.10 [0.98-1.24],0.1135477269137081
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,18247,803,1.12 [0.95-1.33],0.1873292389125542
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,19899,439,1.33 [1.08-1.64],0.0072581852756318
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,16402,260,0.80 [0.55-1.17],0.2541050561110769
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,16379,237,1.25 [0.93-1.66],0.1368969579087955
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,16333,191,1.16 [0.82-1.65],0.395988570240621
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,19947,40,1.54 [0.87-2.71],0.1401128341239166
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,18677,1233,1.21 [1.06-1.38],0.005817309633574
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,17830,325,1.19 [0.91-1.54],0.2011086331660196
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,19601,141,1.42 [1.02-1.99],0.0406802415341135
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,19762,55,1.39 [0.81-2.38],0.2295661857548879
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",16367,225,0.88 [0.59-1.31],0.5300589256787278
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,19743,2238,1.21 [1.09-1.34],0.0002315325050053
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",17559,54,1.30 [0.72-2.33],0.3801949010515993
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,17841,113,1.15 [0.72-1.83],0.5565073947794246
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,19295,62,0.87 [0.42-1.82],0.7137138725458694
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urethral stricture,17689,245,1.09 [0.79-1.50],0.5906302762013642
CEBPA,CCAAT/enhancer-binding protein alpha,Chapter XIV Diseases of the genitourinary system,Urolithiasis,19664,431,1.04 [0.81-1.33],0.7773959033462582
